利用人类-真菌界面的跨王国代谢差异来开发新的治疗方法
Claudio Costantini1, Marilena Pariano1, Matteo Puccetti2
1Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Frontiers in molecular biosciences
|May 9, 2024
概括
作为病原体或共生物,真菌拥有独特的酶,与人类新陈代谢相互作用. 针对这些真菌代谢差异,为各种疾病提供了新的治疗策略.
科学领域:
- 微生物学 微生物学
- 代谢工程是代谢工程.
- 医学真菌学 医学真菌学
背景情况:
- 菌类是人类微生物群的关键成员,表现出从共生主义到致病性的各种生态作用.
- 菌类微生物群 (菌菌群) 的变化与炎症,传染病,代谢疾病和癌症有关.
- 菌类拥有独特的酶谱,与宿主进行代谢交叉对话.
研究的目的:
- 探索针对真菌代谢独特性的新疗法策略的概念.
- 突出利用真菌和宿主之间的跨王国代谢差异的潜力.
- 介绍最近在病理环境中的经验,证明这些代谢差异.
主要方法:
- 复习真菌酶谱及其与宿主代谢的相互作用.
- 分析真菌 (病原体和共生物) 与人类系统之间的代谢交叉对话.
- 案例研究说明了涉及真菌与人类代谢相互作用的病理环境.
主要成果:
- 酶可以提供独特的代谢机会或产生有毒代谢物 (菌毒素).
- 虽然真菌代谢网络含有人类同类的酶,但它们的结构是独特的.
- 菌类和宿主之间的跨王国代谢差异在各种病理条件中很明显.
结论:
- 针对真菌的独特代谢特征,无论是致病性还是共生性,都为开发新疗法提供了有前途的途径.
- 了解真菌特异性代谢途径及其与宿主相互作用对于治疗创新至关重要.
- 利用真菌的代谢单一性有潜力治疗与真菌生物群失生症或真菌感染相关的一系列疾病.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Biological Methods for Microbial Control
1.4K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.4K
Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Introduction to the Human Microbiota
209
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90


